Sector valuations Genmab A/S

Equities

Market Closed - Nasdaq Copenhagen Other stock markets 16:20:00 12/12/2025 GMT			5-day change	1st Jan Change
2,015.00 ^DKK	-1.52%		-0.84%	+35.01%

12-12	Genmab Finalizes Tender Offer for Dutch Biotech Merus	MT
12-12	Genmab Completes Acquisition of Merus – Bolsters Portfolio with New Cancer Treatment	FW

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	Price to Book (N)	PEG (N)	EV / Sales (N)	EV / EBITDA (N)	EV / EBIT (N)	Dividend Yield (N)	Capi.($)
GENMAB A/S	17.26x	3.22x	-4.54x	4.24x	11.37x	11.99x	-.--%	19.5B
ARGENX SE	48.77x	7.96x	1.89x	11.89x	42.72x	44.04x	-.--%	54.11B
INSMED INCORPORATED	-31.96x	63.86x	-3x	81.09x	-35.85x	-35.44x	-.--%	42.02B
WUXI APPTEC CO., LTD.	16.65x	3.93x	0.23x	5.82x	13.2x	14.43x	1.7%	39.6B
BIONTECH SE	-23.83x	1.09x	-1.07x	3.27x	-8.94x	-7.07x	-.--%	22.8B
WUXI BIOLOGICS (CAYMAN) INC.	28.17x	2.6x	0.74x	5.53x	15.34x	19.09x	-.--%	17.76B
AKESO, INC.	-513.74x	14.08x	8.1x	29.73x	701.05x	-597.93x	-.--%	14.73B
SUMMIT THERAPEUTICS INC.	-13.59x	-	-0.05x	170.75x	-26.62x	-13.26x	-.--%	13.55B
MADRIGAL PHARMACEUTICALS, INC.	-57.96x	21.5x	1.05x	13.09x	-55.48x	-49.81x	-.--%	12.98B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-192.75x	23.38x	-2.51x	45.87x	-186.28x	-164.6x	-.--%	13.14B
EXELIXIS, INC.	16.05x	4.21x	0.36x	4.47x	11.08x	12.45x	-.--%	11B
ARROWHEAD PHARMACEUTICALS, INC.	-21.22x	17.61x	-0x	21x	-33.24x	-20.73x	-.--%	9.52B
NUVALENT, INC.	-18.3x	8.69x	-0.4x	-	-18.83x	-18.19x	-.--%	8.14B
CYTOKINETICS, INCORPORATED	-10.01x	-15.3x	-0.49x	89.36x	-12.27x	-11.96x	-.--%	7.75B
ABL BIO INC.	803.95x	42.39x	-6.67x	96.91x	871.78x	1127.71x	-	7.09B
MERUS N.V.	-16.55x	12.93x	-0.22x	126.44x	-19.24x	-18.73x	-.--%	7.35B
Average	1.93x	14.14x	-0.41x	47.30x	79.36x	18.25x	0.11%	18.81B
Weighted average by Cap.	-11.51x	16.55x	-0.22x	36.25x	46.56x	-7.86x	0.23%